An hour with Nightingale recordings
In this episode of An hour with Nightingale, Nightingale Health's Chief Executive Officer Teemu Suna and Chief Scientific Officer Jeffrey Barrett discuss the differences between genetics and Nightingale's blood data and the benefits of combining them.
The event focused on Nightingale’s most recent research and development achievements. At the event Nightingale announced that it will bring new health indicators in the areas of mind health and immunity to its mobile application. Nightingale also announced that the new health indicators and Nightingale’s at-home testing solution will be commercially available on an accelerated timeline already in Q1/2022.